Cost of Illness Associated With Influenza in the UK
Completed
- Conditions
- Influenza
- Interventions
- Other: Data collection
- Registration Number
- NCT01521416
- Lead Sponsor
- GlaxoSmithKline
- Brief Summary
The objective of this study is to describe the burden associated with influenza in the UK, from both primary and secondary care perspectives, and to stratify the burden by the annual degree of mismatch between predicted and actual virus strains.
- Detailed Description
This is a retrospective, cross sectional, exploratory, observational study using database analysis and therefore there is no patient or user group involvement.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 1
Inclusion Criteria
- Male or female patients coded within the database as having acute respiratory events that could be related to an infection between 2001 and 2009.
- Patients must have a minimum of 14 days observation before and after the index event to permit the capturing of complications attributable to influenza.
Exclusion Criteria
Not Applicable
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Cohort Group Data collection -
- Primary Outcome Measures
Name Time Method Incidence of influenza-related events Over the study time period (from January 21st 2001 to March 31st 2009 inclusive) Number of confirmed influenza infections Over the study time period (from January 21st 2001 to March 31st 2009 inclusive) Assessment of resource use Over the study time period (from January 21st 2001 to March 31st 2009 inclusive) Evaluation of patient outcomes, treatments and costs (type and duration) Over the study time period (from January 21st 2001 to March 31st 2009 inclusive) Cause of deaths Over the study time period (from January 21st 2001 to March 31st 2009 inclusive) Incidence of influenza-related events in High Risk groups Over the study time period (from January 21st 2001 to March 31st 2009 inclusive) Incidence of complications and exacerbations Over the study time period (from January 21st 2001 to March 31st 2009 inclusive)
- Secondary Outcome Measures
Name Time Method